The top 10 medical disruptors of 2018

Share

8. Enhanced recovery after surgery

ERAS

[Image from unsplash.com]

Hospital readmissions accounted for $520M in Medicare payouts in 2016. Opioids affect 2 million Americans. With enhanced recovery after surgery (ERAS), clinicians believe they can tackle both problems.

The idea of ERAS permits patients to eat prior to surgery, limits opioid prescriptions by prescribing other medications and encourages regular walks to improve blood flow.

In a study tested ERAS methodology, researchers reports a one-third drop in surgical complications and an opioid prescription reduction of 21%. It also reported that patients went home between two and three days after surgery with low readmission rates of 2%.

ERAS improves quality and reduces healthcare costs, according to Dr. Conor Delaney, chair of the Digestive Disease and Surgery Institute at the Cleveland Clinic.

Next >>

How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.


Register now with the code "TAVR" and save 15% today.

Pages: 1 2 3 4 5 6 7 8 9 10 11

Comments

  1. Very promising disruptions in Healthcare. Will be interested as an incubator to closely track the development of ideas of healthcare startups.

Speak Your Mind

*